Product review of DrugPatentWatch (sources - content & coverage)
Jinfo Article
22nd January 2018
By Scott Vine
Abstract
In part two of our product review of DrugPatentWatch, a database which provides patent information from the US and worldwide along with other actionable business intelligence on small-molecule drugs, we take a look at its strengths and weaknesses and content and sources.
Note: Full review (PDF) at /go/sub/report/2934
Content Access
Does your organisation have a Jinfo Subscription?
Access to Jinfo Content and Community is available through a Jinfo Subscription.
"Yes"
Please sign in to MyJinfo here so that we can check your access to this item:
Or sign in via email:
Enter your email and we'll send you a magic link to sign you in automatically.
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product review of DrugPatentWatch (sources - content & coverage)
- Link to this page
- View printable version
Related articles:
- Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
Wednesday, 24th January 2018 - Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
Tuesday, 23rd January 2018 - Product review of DrugPatentWatch (key advantages; introduction; contact details)
Friday, 19th January 2018 - Mini review of AdisInsight - a "one-stop solution" for pharmaceutical researchers
Wednesday, 15th March 2017
Related reports:
- Product review of DrugPatentWatch
Friday, 19th January 2018